A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults
- Resource Type
- Article
- Source
- In
Vaccine 14 March 2016 34(12):1465-1471 - Subject
- Language
- ISSN
- 0264-410X